For example, high levels of proteins identified in cluster 3 were associated with greater sensitivity to both cisplatin and paclitaxel; yet several of these proteins including c-Src [42], [43] and c-Myc [44], [45] have been shown to be overexpressed in tumor cells and their expression correlates with paclitaxel or cisplatin resistance. This evidence concerns the gene SRC and neoplasm.